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56 Patients in TICU: 
1/6-1/31 2009 12 patients had  thrombocytopenia, 1 patient 



























Crit Care Med 2006 Vol. 34, No. 12.
Points (0, 1, or 2 for Each of Four Categories)
Maximum Possible Score = 8
2 1 0
Thrombocytopenia > 50% fall to     
nadir > 20 x 
109/L
30-50% fall;                   
nadir 10-19 x 109/L
< 30% fall;  
nadir < 10 x 
109/L
Timing                     
of platelet fall
Days 5-10;             
< day 1 + 
heparin         
(past 30 days)
> day 10 / timing unclear;   
< day 1 + heparin          
(past 31-100 days)




Thrombosis New thrombosis; 
skin necrosis;  
acute reaction  
Skin lesions; suspected 
thrombosis (unproven)
None
OTher cause(s) of 
platelet fall
None evident Possible Definite
Pre‐Test Probability of HIT 
(Modified 4Ts)
Crit Care Med 2006 Vol. 34, No. 12.
Points (0, 1, or 2 for Each of Four Categories)
Maximum Possible Score = 8
2 1 0
Thrombocytopenia > 50% 30-50% fall < 30% fall
Timing                     
of platelet fall
Days 5-14 < day 5
Thrombosis New thrombosis; 
skin necrosis;  
acute reaction  
Skin lesions; suspected 
thrombosis (unproven)
None
OTher cause(s) of 
platelet fall
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